Regional analysis of differently phosphorylated tau proteins in brains from patients with Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 17, Issue 3, 2004, Pages 122-131

  Nakano, Hiroyuki ^a,b,c   Kobayashi, Katsuji ^a   Sugimori, Kaoru ^a   Shimazaki, Masao ^a   Miyazu, Kenji ^a   Hayashi, Masahiro ^b   Furuta, Hisakazu ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

^c NONE   (Japan)

Author keywords

Alzheimer's disease; AT180; AT8; HT7; Neurofibrillary tangles; Tau protein; Tau2; Tau5

Indexed keywords

MONOCLONAL ANTIBODY; TAU PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBODY LABELING; ARTICLE; BRAIN CORTEX; CARBOXY TERMINAL SEQUENCE; CINGULATE GYRUS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIMBIC CORTEX; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; SILVER STAINING;

ALZHEIMER DISEASE; ANTIBODIES, MONOCLONAL; BRAIN CHEMISTRY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; NEURONS; PHOSPHORYLATION; SILVER STAINING; TAU PROTEINS;

EID: 1542614533     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076344     Document Type: Article

References (32)

1. Kimura T, Ono T, Takamatsu J, Yamamoto H, Ikegami K, Kondo A, Hasegawa M, Ihara Y, Miyamoto E, Miyakawa T: Sequential changes of tau-site-specific phosphorylation during development of paired helical filaments. Dementia 1996;7:177-181.
2. Su JH, Cummings BJ, Cotman CW: Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites. Neuroreport 1994;5:2358-2362.
3. Kobayashi K, Hayashi M, Nakano H, Fukutani Y, Sasaki K, Shimazaki M, Koshino Y: Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease. Neuropathol Appl Neurobiol 2002;28:238-251.
4. Kobayashi K, Nakano H, Hayashi M, Shimazaki M, Fukutani Y, Sasaki K, Sugimori K, Koshino Y: Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease. J Neurol Sci 2003;208:17-24.
5. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, and participating CERAD neuropathologists: The Consortium to Establish a Registry for Alzheimer's disease (CERAD). 2. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
6. Khachaturian ZS: Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
7. Braak H, Braak E: Neuropathological staging of Alzheimer-related changes. Acta Neuropathol (Berl) 1991;82:239-259.
8. Augustinack JC, Schneider A, Mandelkow EM, Hyman BT: Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Acta Neuropathol (Berl) 2002;103:26-35.
9. Papasozomenos SC: Tau protein immunoreactivity in dementia of the Alzheimer type. 1. Morphology, evolution, distribution, and pathogenetic implications. Lab Invest 1989;60:123-137.
10. Flament S, Delacourte A, Delaere P, Duyckaerts C Hauw JJ: Correlation between microscopical changes and Tau 64 and 69 biochemical detection in senile dementia of the Alzheimer type. Tau 64 and 69 are reliable markers of the neurofibrillary degeneration. Acta Neuropathol (Berl) 1990;80:212-215.
11. Hof PR, Bouras C, Buee L, Delacourte A, Perl DP, Morrison JH: Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease. Acta Neuropathol (Berl) 1992;85:23-30.
12. Vermersch P, Frigard B, Delacourte A: Mapping of neurofibrillary degeneration in Alzheimer's disease: Evaluation of heterogeneity using the quantification of abnormal tau proteins. Acta Neuropathol (Berl) 1992;85:48-54.
13. Vogt BA, Vogt LJ, Vrana KE, Gioia L, Meadows RS, Challa VR, Hof PR, Van Hoesen GW: Multivariate analysis of laminar patterns of neurodegeneration in posterior cingulate cortex in Alzheimer's disease. Exp Neurol 1998;153:8-22.
14. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco, Pasquier F, Petit H, Di Menza C: The biochemical pathways of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 1999;52:1158-1165.
15. Brion JP, Anderton BH, Authelet M, Dayanandan R, Leroy K, Lovestone S, Octave JN, Pradier L, Touchet N, Tremp G: Neurofibrillary tangles and tau phosphorylation. Biochem Soc Symp 2001;67:81-88.
16. Goedert M, Jakes R, Crowther RA, Cohen P, Vanmechelen E, Vandermeeren M, Cras P: Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: Identification of phosphorylation sites in tau protein. Biochem J 1994;301:871-877.
17. Goedert M, Jakes R, Vanmechelen E: Monoclonal antibody AT8 recognizes tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 1995;189:167-169.
18. Papasozomenos SC: Tau protein immunoreactivity in dementia of the Alzheimer type. 2. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments. Lab Invest 1989;60:375-389.
19. Papasozomenos SC, Binder LI: Phosphorylation determines two distinct species of tau in the central nervous system. Cell Motil Cytoskeleton 1987;8:210-226.
20. Watanabe N, Takio K, Hasegawa M, Arai T, Titani K, Ihara Y: Tau 2: A probe for Ser conformation in the amino terminus of tau. J Neurochem 1992;58:960-966.
21. Papasozomenos SC, Su Y: Rapid dephosphorylation of tau in heat-shocked fetal rat cerebral explants: Prevention and hyperphosphorylation by inhibitors of protein phosphatases PP1 and PP2A. J Neurochem 1995;65:396-406.
22. Mercken M, Vandermeeren M, Lubke U, Six J, Boons J, Vanmechelen E, Van de Voorde A, Gheuens J: Affinity purification of human tau proteins and the construction of a sensitive sandwich enzyme-linked immunosorbent assay for human tau detection. J Neurochem 1992;58:548-553.
23. Braak E, Braak H, Mandelkow EM: A sequence of cytoskeletal changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol (Berl) 1994;87:554-567.
24. Uchihara T, Nakamura A, Yamazaki M, Mori O: Evolution from pretangle neurons to neurofibrillary tangles monitored by thiazin red combined with Gallyas method and double immunofluorescence. Acta Neuropathol (Berl) 2001;101:535-539.
25. Iqbal K, Braak E, Braak H, Zaidi T, Grundke-Iqbal I: A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging 1991;12:357-361.
26. Yang SD, Yu JS, Liu WK, Yen SH: Synergistic control mechanism for abnormal site phosphorylation of Alzheimer's disease brain tau by kinase FA/GSK-3 alpha. Biochem Biophys Res Commun 1993;197:400-406.
27. Singh TJ, Zaidi T, Grundke-Iqbal I, Iqbal K: Non-proline-dependent protein kinases phosphorylate several sites found in tau from Alzheimer disease brain. Mol Cell Biochem 1996;154:143-151.
28. Wu JM, Chen Y, Hsieh TC, Brandt R, Lee G: Phosphorylation of native and truncated isoforms of protein tau by the double-stranded DNA-dependent protein kinase (DNA-PK) shows that the primary phosphorylation sites are localized between amino acid residues 212-231 of the longest tau. Biochem Mol Biol Int 1996;40:21-31.
29. Li F, Iseki E, Odawara T, Kosaka K, Yagishita S, Amano N: Regional quantitative analysis of tau-positive neurons in supranuclear palsy: Comparison with Alzheimer's disease. J Neurol Sci 1998;159:73-81.
30. Hof PR, Bouras C, Constantinidis J, Morrison JH: Selective disconnection of specific visual association pathways in cases of Alzheimer's disease presenting with Balint's syndrome. J Neuropathol Exp Neurol 1990;49:168-184.
31. Kaida K, Takeda K, Nagata N, Kamakura K: Alzheimer's disease with asymmetric parietal lobe atrophy: A case report. J Neurol Sci 1998;160:96-99.
32. Mendez MF, Ghajarania M, Perryman KM: Posterior cortical atrophy: Clinical characteristics and differences compared to Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14: 33-40.